Gastric Mucormycosis: An Infection of Fungal Invasion into the Gastric Mucosa in Immunocompromised Patients

被引:4
作者
Naqvi, Haider A. [1 ,2 ,3 ,4 ]
Nadeem Yousaf, Muhammad [1 ,2 ,3 ,4 ]
Chaudhary, Fizah S. [1 ,2 ,3 ,4 ]
Mills, Lawrence [5 ]
机构
[1] Medstar Union Mem Hosp, Dept Med, Baltimore, MD 21218 USA
[2] MedStar Good Samaritan Hosp, Dept Med, Baltimore, MD 21239 USA
[3] MedStar Franklin Sq Med Ctr, Dept Med, Baltimore, MD 21237 USA
[4] MedStar Harbor Hosp, Dept Med, Baltimore, MD 21225 USA
[5] MedStar Good Samaritan Hosp, Dept Gastroenterol, Baltimore, MD 21239 USA
关键词
STEM-CELL TRANSPLANT; GASTROINTESTINAL MUCORMYCOSIS; EMPHYSEMATOUS GASTRITIS; RARE; EPIDEMIOLOGY; ZYGOMYCOSIS; GUIDELINES; RECIPIENT; DIAGNOSIS; NECROSIS;
D O I
10.1155/2020/8876125
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary gastric mucormycosis is a rare but potentially lethal fungal infection due to the invasion of Mucorales into the gastric mucosa. It may result in high mortality due to increased risk of complications in immunocompromised patients. Common predisposing risk factors to develop gastric mucormycosis are prolonged uncontrolled diabetes mellitus with or without diabetic ketoacidosis (DKA), solid organ or stem cell transplantation, underlying hematologic malignancy, and major trauma. Abdominal pain, hematemesis, and melena are common presenting symptoms. The diagnosis of gastric mucormycosis can be overlooked due to the rarity of the disease. A high index of suspicion is required for early diagnosis and management of the disease, particularly in immunocompromised patients. Radiological imaging findings are nonspecific to establish the diagnosis, and gastric biopsy is essential for histological confirmation of mucormycosis. Prompt treatment with antifungal therapy is the mainstay of treatment with surgical resection reserved in cases of extensive disease burden or clinical deterioration. We presented a case of acute gastric mucormycosis involving the body of stomach in a patient with poorly controlled diabetes and chronic renal disease, admitted with acute onset of abdominal pain. Complete resolution of lesion was noted with 16 weeks of medical treatment with intravenous amphotericin B and posaconazole.
引用
收藏
页数:7
相关论文
共 50 条
[31]  
Paulo De Oliveira Jose Egidio, 2002, Endocr Pract, V8, P44
[32]   Epidemiology and Clinical Manifestations of Mucormycosis [J].
Petrikkos, George ;
Skiada, Anna ;
Lortholary, Olivier ;
Roilides, Emmanuel ;
Walsh, Thomas J. ;
Kontoyiannis, Dimitrios P. .
CLINICAL INFECTIOUS DISEASES, 2012, 54 :S23-S34
[33]   Gastric Mucormycosis and Pneumatosis in a Patient With APECED [J].
Platt, Jesse M. ;
Chu, Jacqueline N. ;
Yarze, Joseph C. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 :S1500-S1500
[34]  
Putrus A, 2015, GASTROENTEROLOGY, V148, pS321
[35]  
Raviraj K Sunil, 2015, J Assoc Physicians India, V63, P75
[36]   Epidemiology and outcome of zygomycosis: A review of 929 reported cases [J].
Roden, MM ;
Zaoutis, TE ;
Buchanan, WL ;
Knudsen, TA ;
Sarkisova, TA ;
Schaufele, RL ;
Sein, M ;
Sein, T ;
Chiou, CC ;
Chu, JH ;
Kontoyiannis, DP ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (05) :634-653
[37]   Mucormycosis: an unusual cause of gastric perforation and severe bleeding in immunocompetent patients [J].
Sanchez-Velazquez, Patricia ;
Pera, Manuel ;
Gimeno, Javier ;
Zapatero, Ana ;
Nolla, Juan ;
Pera, Miguel .
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017, 109 (03) :223-+
[38]  
Sasaki A, 1993, Rinsho Byori, V41, P1054
[39]   Gastric Ulcer and Perforation due to Mucormycosis in an Immunocompetent Patient [J].
Sehmbey, Gurbir ;
Malik, Rameez ;
Kosa, Dimas ;
Srinivasan, Indu ;
Chuang, Keng-Yu ;
Bellapravalu, Sharad .
ACG CASE REPORTS JOURNAL, 2019, 6 (08)
[40]   Successful management of emphysematous gastritis with invasive gastric mucormycosis [J].
Sharma, Digvijoy .
BMJ CASE REPORTS, 2020, 13 (02)